FMP

FMP

Enter

MRNA - Moderna, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/MRNA.png

Moderna, Inc.

MRNA

NASDAQ

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

42.57 USD

0.39 (0.916%)

Balance Sheet

Year

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Total Cash

1.1B

4.61B

10.73B

9.9B

8.6B

7.67B

10.44B

14.2B

19.32B

26.28B

Total Cash %

2.3k

1.68k

60.48

51.4

125.64

82.38

82.38

82.38

82.38

Receivables

5.37M

1.41B

3.17B

1.39B

892M

2.78B

3.78B

5.15B

7B

9.53B

Receivables %

11.18

512.95

17.9

7.19

13.03

29.86

29.86

29.86

29.86

Inventories

-

47M

1.44B

949M

202M

617.16M

839.59M

1.14B

1.55B

2.11B

Inventories %

-

17.12

8.12

4.93

2.95

6.62

6.62

6.62

6.62

Payable

7.09M

18M

302M

487M

520M

617.5M

840.04M

1.14B

1.55B

2.11B

Payable %

14.76

6.56

1.7

2.53

7.59

6.63

6.63

6.63

6.63

Cap Ex

-31.55M

-67.45M

-284M

-400M

-707M

-1.94B

-2.64B

-3.6B

-4.89B

-6.65B

Cap Ex %

-65.69

-24.57

-1.6

-2.08

-10.32

-20.85

-20.85

-20.85

-20.85

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep